News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,454 Results
Type
Article (50645)
Company Profile (281)
Press Release (713516)
Multimedia
Podcasts (155)
Webinars (23)
Section
Business (216001)
Career Advice (2543)
Deals (36613)
Drug Delivery (132)
Drug Development (84305)
Employer Resources (180)
FDA (17087)
Job Trends (15741)
News (363857)
Policy (34782)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2761)
Academic (1)
Accelerated approval (34)
Adcomms (27)
Allergies (151)
Alliances (53218)
ALS (178)
Alzheimer's disease (1718)
Antibody-drug conjugate (ADC) (325)
Approvals (17337)
Artificial intelligence (574)
Autoimmune disease (164)
Automation (41)
Bankruptcy (368)
Best Places to Work (12035)
BIOSECURE Act (22)
Biosimilars (197)
Biotechnology (185)
Bladder cancer (160)
Brain cancer (60)
Breast cancer (661)
Cancer (4990)
Cardiovascular disease (423)
Career advice (2155)
Career pathing (41)
CAR-T (294)
CDC (52)
Celiac Disease (2)
Cell therapy (794)
Cervical cancer (37)
Clinical research (71738)
Collaboration (1810)
Company closure (5)
Compensation (1179)
Complete response letters (61)
COVID-19 (2862)
CRISPR (99)
C-suite (886)
Cystic fibrosis (147)
Data (6361)
Decentralized trials (2)
Denatured (54)
Depression (143)
Diabetes (517)
Diagnostics (6926)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (280)
Drug pricing (207)
Drug shortages (31)
Duchenne muscular dystrophy (239)
Earnings (94143)
Editorial (65)
Employer branding (23)
Employer resources (160)
Events (124034)
Executive appointments (1020)
FDA (20280)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1532)
Gene editing (212)
Generative AI (57)
Gene therapy (642)
GLP-1 (1037)
Government (5002)
Grass and pollen (8)
Guidances (385)
Healthcare (19757)
HIV (61)
Huntington's disease (47)
IgA nephropathy (85)
Immunology and inflammation (272)
Immuno-oncology (60)
Indications (116)
Infectious disease (3144)
Inflammatory bowel disease (201)
Inflation Reduction Act (16)
Influenza (121)
Intellectual property (258)
Interviews (437)
IPO (16913)
IRA (57)
Job creations (4056)
Job search strategy (1785)
JPM (68)
Kidney cancer (16)
Labor market (88)
Layoffs (582)
Leadership (37)
Legal (8648)
Liver cancer (93)
Longevity (15)
Lung cancer (667)
Lymphoma (386)
Machine learning (43)
Management (62)
Manufacturing (837)
MASH (172)
Medical device (14193)
Medtech (14250)
Mergers & acquisitions (20797)
Metabolic disorders (1336)
Multiple sclerosis (169)
NASH (18)
Neurodegenerative disease (342)
Neuropsychiatric disorders (94)
Neuroscience (3010)
Neurotech (1)
NextGen: Class of 2026 (6930)
Non-profit (4841)
Now hiring (67)
Obesity (635)
Opinion (310)
Ovarian cancer (169)
Pain (205)
Pancreatic cancer (234)
Parkinson's disease (293)
Partnered (37)
Patents (517)
Patient recruitment (509)
Peanut (60)
People (61880)
Pharmaceutical (65)
Pharmacy benefit managers (32)
Phase 1 (22285)
Phase 2 (31417)
Phase 3 (23610)
Pipeline (5481)
Policy (317)
Postmarket research (2825)
Preclinical (9629)
Press Release (67)
Prostate cancer (249)
Psychedelics (52)
Radiopharmaceuticals (294)
Rare diseases (883)
Real estate (6344)
Recruiting (73)
Regulatory (25718)
Reports (54)
Research institute (2518)
Resumes & cover letters (415)
Rett syndrome (27)
RNA editing (18)
RSV (82)
Schizophrenia (153)
Series A (253)
Series B (196)
Service/supplier (12)
Sickle cell disease (102)
Special edition (26)
Spinal muscular atrophy (161)
Sponsored (45)
Startups (3810)
State (2)
Stomach cancer (19)
Supply chain (112)
Tariffs (91)
The Weekly (99)
Vaccines (1088)
Venture capital (96)
Weight loss (418)
Women's health (94)
Worklife (19)
Date
Today (168)
Last 7 days (615)
Last 30 days (2357)
Last 365 days (31026)
2026 (3906)
2025 (31250)
2024 (36141)
2023 (40974)
2022 (52260)
2021 (56969)
2020 (55647)
2019 (48619)
2018 (36730)
2017 (33801)
2016 (33721)
2015 (39693)
2014 (33858)
2013 (29338)
2012 (31253)
2011 (31654)
2010 (30086)
Location
Africa (900)
Alabama (86)
Alaska (7)
Arizona (316)
Arkansas (14)
Asia (42664)
Australia (7074)
California (11524)
Canada (3344)
China (1148)
Colorado (492)
Connecticut (502)
Delaware (343)
Europe (94455)
Florida (1721)
Georgia (364)
Hawaii (3)
Idaho (62)
Illinois (904)
India (69)
Indiana (536)
Iowa (23)
Japan (440)
Kansas (131)
Kentucky (40)
Louisiana (26)
Maine (75)
Maryland (1421)
Massachusetts (8340)
Michigan (344)
Minnesota (636)
Mississippi (5)
Missouri (134)
Montana (32)
Nebraska (29)
Nevada (124)
New Hampshire (82)
New Jersey (3097)
New Mexico (31)
New York (3040)
North Carolina (1536)
North Dakota (9)
Northern California (5611)
Ohio (344)
Oklahoma (22)
Oregon (42)
Pennsylvania (2316)
Puerto Rico (24)
Rhode Island (49)
South America (1280)
South Carolina (66)
South Dakota (1)
Southern California (4493)
Tennessee (180)
Texas (1783)
United States (41103)
Utah (343)
Vermont (1)
Virginia (277)
Washington D.C. (84)
Washington State (931)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
764,454 Results for "john wiley and sons inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
2026 Could Mark a Turning Point for American Innovation
The current state of political affairs in the U.S. does not bode well for the direction of that turn. The country is at real risk of losing its long-held lead in biotech innovation.
February 16, 2026
·
4 min read
·
John Stanford
Press Releases
JenaValve Appoints John Molyneux to Vice President of Operations
January 29, 2026
·
2 min read
Press Releases
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
February 18, 2026
·
3 min read
Press Releases
23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer
December 10, 2025
·
2 min read
Press Releases
Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors
February 9, 2026
·
2 min read
Press Releases
Telo Genomics Announces Appointment of John Price as Chief Financial Officer
January 29, 2026
·
2 min read
Press Releases
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 6, 2026
·
6 min read
Press Releases
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
January 15, 2026
·
5 min read
Press Releases
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
January 8, 2026
·
3 min read
Press Releases
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
December 30, 2025
·
4 min read
1 of 76,446
Next
